Bing Cui Selected Research

4-chlorobenzyltetrahydroberberine

12/2005	Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway.
11/2005	CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Cui Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 01/2009
10	Inflammation (Inflammations) 11/2021 - 01/2009
8	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 07/2008
8	Leukemia 12/2017 - 01/2012
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2017 - 02/2013
7	Fibrosis (Cirrhosis) 01/2020 - 06/2008
6	Neoplasm Metastasis (Metastasis) 12/2019 - 06/2013
4	Breast Neoplasms (Breast Cancer) 12/2019 - 01/2012
3	Lung Injury 10/2021 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2011
3	Pulmonary Hypertension 02/2009 - 11/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 03/2018
2	Lymphoma (Lymphomas) 12/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2011
2	Acute Promyelocytic Leukemia 01/2020 - 01/2017
2	Dyslipidemias (Dyslipidemia) 01/2020 - 03/2018
2	Cardiomegaly (Heart Hypertrophy) 10/2019 - 10/2010
2	Obesity 03/2018 - 11/2016
2	Insulin Resistance 03/2018 - 11/2016
2	Wounds and Injuries (Trauma) 05/2015 - 05/2007
2	Hypoxia (Hypoxemia) 12/2014 - 12/2005
1	Lung Diseases (Lung Disease) 01/2022
1	Hyperuricemia 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Sepsis (Septicemia) 11/2021
1	Genetic Translocation (Chromosomal Translocation) 12/2020
1	Starvation 12/2020
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Fatigue 10/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2012
5	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 12/2017 - 01/2012
4	Peptides (Polypeptides)IBA 12/2020 - 01/2019
4	CytokinesIBA 09/2019 - 08/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 12/2020 - 05/2015
3	cirmtuzumabIBA 01/2019 - 12/2014
3	Monoclonal AntibodiesIBA 01/2019 - 04/2013
3	Insulin (Novolin)FDA Link 03/2018 - 08/2015
3	Therapeutic UsesIBA 03/2018 - 11/2005
3	Biological ProductsIBA 08/2015 - 12/2011
3	Pharmaceutical PreparationsIBA 09/2014 - 08/2010
3	MonocrotalineIBA 02/2009 - 02/2004
3	Endothelins (Endothelin)IBA 02/2009 - 11/2005
2	Chemokine CCL1IBA 10/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 10/2019
2	Thioacetamide (Thioacetamid)IBA 01/2020 - 02/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019 - 08/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2019 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 09/2019 - 02/2017
2	EnzymesIBA 01/2019 - 12/2005
2	Glycogen Synthase (Synthase I)IBA 01/2019 - 10/2010
2	UbiquitinIBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 12/2014
2	ChemokinesIBA 12/2017 - 08/2009
2	Surface Antigens (Surface Antigen)IBA 12/2017 - 12/2012
2	Messenger RNA (mRNA)IBA 11/2017 - 12/2014
2	Toll-Like Receptor 2IBA 05/2015 - 08/2010
2	Small Interfering RNA (siRNA)IBA 12/2014 - 12/2014
2	MicroRNAs (MicroRNA)IBA 12/2014 - 07/2014
2	AntigensIBA 01/2014 - 12/2012
2	Oxygen (Dioxygen)IBA 02/2013 - 12/2005
2	CollagenIBA 01/2012 - 01/2005
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2012 - 08/2010
2	CalciumIBA 02/2009 - 12/2005
2	CPU0213IBA 02/2009 - 05/2007
2	Nifedipine (Adalat)FDA LinkGeneric 02/2009 - 12/2005
2	VaccinesIBA 06/2008 - 01/2005
2	4-chlorobenzyltetrahydroberberineIBA 12/2005 - 11/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	DiureticsIBA 01/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	STAT1 Transcription FactorIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	Sirtuin 1IBA 11/2021
1	Taurine FDA Link 11/2021
1	Long Noncoding RNAIBA 11/2021
1	Thyroid HormonesIBA 01/2021
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2020
1	TeaIBA 12/2020
1	ResistinIBA 01/2020
1	LeptinIBA 01/2020
1	LipidsIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ArsenicIBA 01/2020
1	activin AIBA 01/2020
1	AluminumIBA 10/2019
1	AlloysIBA 10/2019
1	LithiumIBA 10/2019

Therapy/Procedure

14	Therapeutics 01/2022 - 01/2009
4	Drug Therapy (Chemotherapy) 12/2019 - 07/2008
3	Ligation 11/2021 - 02/2017
1	Immunotherapy 01/2022
1	Punctures 11/2021
1	Radiotherapy 12/2019